Top

International Journal of Colorectal Disease

Published in:

01-06-2008 | Original Article

hTERT expression in colorectal adenocarcinoma: correlations with p21, p53 expressions and clinicopathological features

Authors: Alfred King-Yin Lam, Kate Ong, Yik-Hong Ho

Published in: International Journal of Colorectal Disease | Issue 6/2008

Abstract

Background

The clinicopathological roles and relationships of hTERT, p21 and p53 proteins have not been studied in depth in colorectal cancer. The aim of the present study is to investigate the clinicopathological roles of expression of hTERT protein expression and its relationship with the expression of p21 and p53 proteins in a large cohort of patients with colorectal adenocarcinoma.

Materials and methods

Expressions of hTERT, p21 and p53 proteins were investigated in 188 patients with colorectal adenocarcinomas by immunohistochemistry. The findings were correlated with the clinicopathological features and survival data of colorectal adenocarcinomas.

Results

hTERT, p53 and p21 proteins were detected in 63%, 100% and 62% of the patients with colorectal carcinoma. High level of hTERT protein expression was noted in patients with metastases (p = 0.038) and in patients with rectal cancer (p = 0.046). Loss or low level of p21 protein was often noted in non-mucinous colorectal adenocarcinoma when compared with mucinous adenocarcinoma (p = 0.001). Furthermore, p53 expression was more frequently noted in non-mucinous adenocarcinoma (p = 0.001). The level of expression of p21 protein was positively correlated with expression of level of hTERT protein (p = 0.00001). The survival of the patients was related to staging (p = 0.001) and p53 protein expression (p = 0.038) of the tumours.

Conclusions

hTERT protein expression is an indicator of the biological aggressiveness of the cancer. The level of expression of the protein was also related to the distal location and level of p21 expression of the tumours.

Hollstein M, Sidransky D, Vogelstein B, Harris CC (1991) p53 mutations in human cancers. Science 253:49–53PubMedCrossRef

Shay JW, Bacchetti S (1997) A survey of telomerase activity in human cancer. Eur J Cancer 33:787–791PubMedCrossRef

Shay JW, Wright WE (2007) Hallmarks of telomeres in aging research. J Pathol 211:114–123PubMedCrossRef

Dudkina AS, Lindsley CW (2007) Small molecule protein–protein inhibitors for the p53–MDM2 interaction. Curr Top Med Chem 7:952–960PubMedCrossRef

Alpan RS, Pardee AB (1996) p21WAF1/CIP1/SDI1 is elevated through a p53-independent pathway by mimosine. Cell Growth Differ 7:893–901PubMed

Lam KY, Lo CY, Chan KW, Wan KY (2000) Insular and anaplastic carcinoma of the thyroid: A 45-year comparative study at a single institution and a review of the significance of p53 and p21. Ann Surg 231:329–338PubMedCrossRef

Yuen APW, Lam KY, Choy JTH, Ho WK, Wei WI (2000) Clinicopathological significance of p53 and p21 expression in the surgical treatment of laryngeal carcinoma. Anticancer Res 20:4863–4866PubMed

Lam KY, Law S, Lo T, Tung HM, Wong J (1999) The clinicopathological significance of p21 and p53 expression in esophageal squamous cell carcinoma: an analysis of 153 patients. Am J Gastroenterol 94:2060–2068PubMedCrossRef

Ng IOL, Lam KY, Ng M, Regezi JA (1999) Expression of p21/waf1 in oral squamous cell carcinomas—correlation with p53 and msdm2 and cellular proliferation index. Oral Oncol 35:63–69PubMedCrossRef

10.

Mabruk MJ, O’Flatharta C (2005) Telomerase: is it the future diagnostic and prognostic tool in human cancer? Expert Rev Mol Diagn 5:907–916PubMedCrossRef

11.

Yan P, Benhattar J, Seelentag W, Stehle JC, Bosman FT (2004) Immunohistochemical localization of hTERT protein in human tissues. Histochem Cell Biol 121:391–397PubMedCrossRef

12.

Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics 2002. CA Cancer J Clin 55:74–108PubMedCrossRef

13.

Schwandner O, Bruch HP, Broll R (2002) p21, p27, cyclin D1, and p53 in rectal cancer: immunohistology with prognostic significance? Int J Colorectal Dis 17:11–19PubMedCrossRef

14.

Girlando S, Slomp P, Caffo O, Amichetti M, Togni R, Dvornik G, Tomio L, Galligioni E, Dalla Palma P, Barbareschi M (1999) p21 expression in colorectal carcinomas: a study on 103 cases with analysis of p53 gene mutation/expression and clinic–pathological correlations. Virchows Arch 43:559–565CrossRef

15.

Malaska J, Kunicka Z, Borsky M, Sklenickova M, Novotna M, Fajkusova L, Zaloudik J, Fajkus J (2004) Telomerase as a diagnostic and predictive marker in colorectal carcinoma. Neoplasma 51:90–96PubMed

16.

Saleh S, Lam A, Ho YH (2008) Real-time PCR quantification of human telomerase reverse transcriptase (hTERT) in colorectal cancer. Pathology 40:25–30PubMedCrossRef

17.

Hamilton SR, Vogelstein B, Kudo S et al (2000) Carcinoma of the colon and rectum. In: Hamilton SR, Aaltonen LA (eds) WHO classification of tumours: pathology and genetics of tumours of digestive system. IARC, Lyon, France, pp 105–119

18.

Greene FL, Page DL, Fleming ID, Fritz A, Balch CM, Haller DG, Morrow M (eds) (2002) AJCC cancer staging manual, 6th edn. Springer, New York

19.

Shats I, Milyavsky M, Tang X, Stambolsky P, Erez N, Brosh R, Kogan I, Braunstein I, Tzukerman M, Ginsberg D, Rotter V (2004) p53-dependent down-regulation of telomerase is mediated by p21waf1. J Biol Chem 279:50976–50985PubMedCrossRef

20.

Ohnishi T, Watanabe T, Nozawa H, Nagawa H (2006) Telomerase subunit immunoreactivity and recurrence in colorectal cancer. Hepatogastroenterology 53:188–191PubMed

21.

Domont J, Pawlik TM, Boige V, Rose M, Weber JC, Hoff PM, Brown TD, Zorzi D, Morat L, Pignon JP, Rashid A, Jaeck D, Sabatier L, Elias D, Tursz T, Soria JC, Vauthey JN (2005) Catalytic subunit of human telomerase reverse transcriptase is an independent predictor of survival in patients undergoing curative resection of hepatic colorectal metastases: a multicenter analysis. J Clin Oncol 23:3086–3093PubMedCrossRef

22.

Wu YL, Dudognon C, Nguyen E, Hillion J, Pendino F, Tarkanyi I, Aradi J, Lanotte M, Tong JH, Chen GQ, Segal-Bendirdjian E (2006) Immunodetection of human telomerase reverse-transcriptase (hTERT) re-appraised: nucleolin and telomerase cross paths. J Cell Sci 119:2797–2806PubMedCrossRef

23.

Lam AK, Ong K, Ho YH (2006) Colorectal mucinous adenocarcinoma: the clinicopathologic features and significance of p16 and p53 expression. Dis Colon Rectum 49:1275–1283CrossRef

24.

Lam KY, Lo CY, Wat NMS, Luk JM, Lam KSL (2001) The clinicopathological features and importance of p53, Rb and mdm2 expression in phaeochromocytomas and paragangliomas. J Clin Pathol 54:443–448PubMedCrossRef

25.

Chow V, Yuen APW, Lam KY, Ho WK, Wei WI (2001) Prognostic significance of serum p53 protein and p53 antibody in patients with surgical treatment for head and neck squamous cell carcinoma. Head Neck 23:286–291PubMedCrossRef

26.

Lam KY, Law S, Tung PH, Wong J (2000) Esophageal small cell carcinoma: clinicopathologic parameters, p53 overexpression, proliferative marker, and their impact on pathogenesis. Arch Pathol Lab Med 124:228–233PubMed

27.

28.

Iacopetta B (2002) Are there two sides to colorectal cancer? Int J Cancer 101:403–408PubMedCrossRef

29.

Kapiteijn E, Liefers GJ, Los LC et al (2001) Mechanisms of oncogenesis in colon versus rectal cancer. J Pathol 195:171–178PubMedCrossRef

30.

Birkenkamp-Demtroder K, Olesen SH, Sorensen FB, Laurberg S, Laiho P, Aaltonen LA, Orntoft TF (2005) Differential gene expression in colon cancer of the caecum versus the sigmoid and rectosigmoid. Gut 54:374–384PubMedCrossRef

Title: hTERT expression in colorectal adenocarcinoma: correlations with p21, p53 expressions and clinicopathological features
Authors: Alfred King-Yin Lam
Kate Ong
Yik-Hong Ho
Publication date: 01-06-2008
Publisher: Springer-Verlag
Published in: International Journal of Colorectal Disease / Issue 6/2008
Print ISSN: 0179-1958
Electronic ISSN: 1432-1262
DOI: https://doi.org/10.1007/s00384-008-0455-7

Keynote webinar | Spotlight on medication adherence

Springer Medicine

hTERT expression in colorectal adenocarcinoma: correlations with p21, p53 expressions and clinicopathological features

Abstract

Background

Materials and methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Materials and methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 6/2008

Rebampide enema therapy as a treatment for patients with chronic radiation proctitis: initial treatment or when other methods of conservative management have failed

Colorectal cancer in the elderly—surgical treatment and long-term survival

A local imbalance between MMP and TIMP may have an implication on the severity and course of appendicitis

Gene profiling of colonic serrated adenomas by using oligonucleotide microarray

Survival and symptomatic benefit from palliative primary tumor resection in patients with metastatic colorectal cancer: a review

Diverticular disease increases and effects younger ages: an epidemiological study of 10-year trends